Clinical Study
Epidemiological Characteristics and Survival Studies of Rhabdomyosarcoma in East Egypt: A Five-Year Multicenter Study
Figure 1
Overall survival (OS) of patients. The estimated OS rate was 56.9% ± 8.4 with mean OS time of 47.8 months ±5.